Fig. 1: Swimmer plot capturing best response, time to progression (TTP) on study (TTP2), time to progression on prior therapy (TTP1), TTP ratio, and status at last follow-up on an individual patient basis. | npj Precision Oncology

Fig. 1: Swimmer plot capturing best response, time to progression (TTP) on study (TTP2), time to progression on prior therapy (TTP1), TTP ratio, and status at last follow-up on an individual patient basis.

From: A signal-seeking phase 2 study of tremelimumab in advanced cancers with high tumour mutational burden

Fig. 1

TR0195 does not display a TTP2 bar as the patient did not experience progression on study. TTP ratio has been calculated using the censor date for TTP2. EOT end of treatment, PR partial response, SD stable disease, PD progressive disease.

Back to article page